Skip to main content

Competing Risks Models and Breast Cancer: A Brief Review

  • Conference paper
  • First Online:
  • 1939 Accesses

Part of the book series: Lecture Notes in Statistics ((LNSP,volume 215))

Abstract

In this paper, we present a brief overview of the methods which are commonly used for statistical analysis of data in competing risks settings. Moreover, we review 37 recent published clinical papers on breast cancer which consider an event of interest, such as breast cancer incident, while they also take into account the competing events, such as death due to other causes. The papers are selected based on the number of citations and publication year.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   179.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Pintilie, M.: Competing Risks: A Practical Perspective. Wiley, New York (2006)

    Book  Google Scholar 

  2. Kalbfleisch, J.D., Prentice, R.L.: The Statistical Analysis of Failure Time Data, 1st edn. Wiley, New York (1980)

    MATH  Google Scholar 

  3. Putter, H., Ficco, M., Geskus, R.B.: Tutorial in biostatistics: competing risks and multi-state models. Stat. Med. 26(11), 2389–2430 (2007)

    Article  MathSciNet  Google Scholar 

  4. Fine, J.P., Gray, R.J.: A proportional hazards model for the subdistribution of a competing risk. J. Am. Stat. Assoc. 94(446), 496–509 (1999)

    Article  MathSciNet  MATH  Google Scholar 

  5. Pepe, M.S., Mori, M.: Kaplan-meier, marginal or conditional probability curves in summarizing competing risks failure time data? Stat. Med. 12(8), 737–751 (1993)

    Article  Google Scholar 

  6. Travis, L.B., Hill, D., Dores, G.M., et al.: Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma. J. Natl. Cancer Inst. 97, 1428–1437 (2005)

    Article  Google Scholar 

  7. Degnim, A.C., Visscher, D.W., Berman, H.K., et al.: Stratification of breast cancer risk in women with atypia: a Mayo cohort study. J. Clin. Oncol. 25, 2671–2677 (2007)

    Article  Google Scholar 

  8. Hwang, E.S., McLennan, J.L., Moore, D.H., et al.: Ductal carcinoma in situ in BRCA mutation carriers. J. Clin. Oncol. 25(6), 642–647 (2007)

    Article  Google Scholar 

  9. Kerlikowske, K., Molinaro, A.M., Gauthier, M.L., et al.: Biomarker expression and risk of subsequent tumors after initial ductal carcinoma in situ diagnosis. J. Natl. Cancer Inst. 102, 627–637 (2010)

    Article  Google Scholar 

  10. Kurian, A.W., Fish, K., Shema, S., et al.: Lifetime risks of specific breast cancer subtypes among women in four racial/ethnic groups. Breast Cancer Res. 12(6), R99 (2010)

    Article  Google Scholar 

  11. Yi, M., Hunt, K.K., Arun, B.K., et al.: Factors affecting the decision of breast cancer patients to undergo contralateral prophylactic mastectomy. Cancer Prev. Res. 3(8), 1026–1034 (2010)

    Article  Google Scholar 

  12. Biggar, R.J., Wohlfahrt, J., Oudin, A., et al.: Digoxin use and the risk of breast cancer in women. J. Clin. Oncol. 29(16), 2165–2170 (2011)

    Article  Google Scholar 

  13. Luo, J., Horn, K., Ockene, J.K., et al.: Interaction between smoking and obesity and the risk of developing breast cancer among postmenopausal women: the Women’s Health Initiative Observational Study. Am. J. Epidemiol. 174(8), 919–928 (2011)

    Article  Google Scholar 

  14. Petracci, E., Decarli, A., Schairer, C., et al.: Risk factor modification and projections of absolute breast cancer risk. J. Natl. Cancer Inst. 103(13), 1037–1048 (2011)

    Article  Google Scholar 

  15. Warner, E., Hill, K., Causer, P., et al.: Prospective study of breast cancer incidence in women with a BRCA1 or BRCA2 mutation under surveillance with and without magnetic resonance imaging. J. Clin. Oncol. 29, 1664–1669 (2011)

    Article  Google Scholar 

  16. Taghipour, S., Banjevic, D., Fernandes, J., et al.: Incidence of invasive breast cancer in the presence of competing mortality: The Canadian National Breast Screening Study. Breast Cancer Res. Treat. 134(2), 839–851 (2012)

    Article  Google Scholar 

  17. Schairer, C., Mink, P.J., Carroll, L., et al.: Probabilities of death from breast cancer and other causes among female breast cancer patients. J. Natl. Cancer Inst. 96(17), 1311–1321 (2004)

    Article  Google Scholar 

  18. Dalton, S.O., Ross, L., During, M., et al.: Influence of socioeconomic factors on survival after breast cancer – a nationwide cohort study of women diagnosed with breast cancer in Denmark 1983–1999. Int. J. Cancer 121, 2524–2531 (2007)

    Article  Google Scholar 

  19. Hanrahan, E.O., Gonzalez-Angulo, A.M., Giordano, S.H., et al.: Overall survival and cause-specific mortality of patients with stage T1a, bN0M0 breast carcinoma. J. Clin. Oncol. 25, 4952–4960 (2007)

    Article  Google Scholar 

  20. Chapman, J.A., Meng, D., Shepherd, L., et al.: Competing causes of death from a randomized trial of extended adjuvant endocrine therapy for breast cancer. J. Natl. Cancer Inst. 100(4), 252–260 (2008)

    Article  Google Scholar 

  21. Newcomb, P.A., Egan, K.M., Trentham-Dietz, A., et al.: Prediagnostic use of hormone therapy and mortality after breast cancer. Cancer Epidemiol. Biomarkers Prev. 7(4), 864–871 (2008)

    Article  Google Scholar 

  22. Kalinsky, K., Jacks, L.M., Heguy, A., et al.: PIK3CA mutation associates with improved outcome in breast cancer. Clin. Cancer Res. 15(16), 5049–5059 (2009)

    Article  Google Scholar 

  23. Komenaka, I.K., Martinez, M.E., Pennington Jr., R.E., et al.: Race and ethnicity and breast cancer outcomes in an underinsured population. J. Natl. Cancer Inst. 102(15), 1178–1187 (2010)

    Article  Google Scholar 

  24. Vinh-Hung, V., Joseph, S.A., Coutty, N., et al.: Age and axillary lymph node ratio in postmenopausal women with T1-T2 node positive breast cancer. Oncologist 15, 1050–1062 (2010)

    Article  Google Scholar 

  25. Fisher, B., Bryant, J., Dignam, J.J., et al.: Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less. J. Clin. Oncol. 20(20), 4141–4149 (2002)

    Article  Google Scholar 

  26. Dignam, J.J., Wieand, K., Johnson, K.A., et al.: Effects of obesity and race on prognosis in lymph node-negative, estrogen receptor-negative breast cancer. Breast Cancer Res. Treat. 97, 245–254 (2006)

    Article  Google Scholar 

  27. Nottage, M.K., Kopciuk, K.A., Tzontcheva, A., et al.: Analysis of incidence and prognostic factors for ipsilateral breast tumour recurrence and its impact on disease-specific survival of women with nodenegative breast cancer: a prospective cohort study. Breast Cancer Res. 8, R44 (2006)

    Article  Google Scholar 

  28. Nguyen, P.L., Taghian, A.G., Katz, M.S., et al.: Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy. J. Clin. Oncol. 26(14), 2373–2378 (2008)

    Article  Google Scholar 

  29. Schaapveld, M., Visser, O., Louwman, W.J., et al.: The impact of adjuvant therapy on contralateral breast cancer risk and the prognostic significance of contralateral breast cancer: a population based study in the Netherlands. Breast Cancer Res. Treat. 110, 189–197 (2008)

    Article  Google Scholar 

  30. Yerushalmi, R., Kennecke, H., Woods, R., Olivotto, I.A., Speers, C., Gelmon, K.A.: Does multicentric/multifocal breast cancer differ from unifocal breast cancer? An analysis of survival and contralateral breast cancer incidence. Breast Cancer Res. Treat. 117(2), 365–370 (2009)

    Article  Google Scholar 

  31. Mell, L.K., Jeong, J., Nichols, M.A., et al.: Predictors of competing mortality in early breast cancer. Cancer 116(23), 5365–5373 (2010)

    Article  Google Scholar 

  32. Galimberti, V., Botteri, E., Chifu, C., et al.: Can we avoid axillary dissection in the micrometastatic sentinel node in breast cancer? Breast Cancer Res. Treat. 131, 819–825 (2012)

    Article  Google Scholar 

  33. Nsouli-Maktabi, H., Henson, D., Younes, N., Young, H., Cleary, S.: Second primary breast, endometrial, and ovarian cancers in Black and White breast cancer survivors over a 35-year time span: effect of age. Breast Cancer Res. Treat. 129(3), 963–969 (2011)

    Article  Google Scholar 

  34. Crump, M., Tu, D., Sheperd, L., et al.: Risk of acute leukemia following epirubicin-based adjuvant chemotherapy: a report from the National Cancer Institute of Canada Clinical Trials Group. J. Clin. Oncol. 21(16), 3066–3071 (2003)

    Article  Google Scholar 

  35. Ryberg, M., Nielsen, D., Osterlind, K., et al.: Predictors of central nervous system metastasis in patients with metastatic breast cancer. A competing risk analysis of 579 patients treated with epirubicin-based chemotherapy. Breast Cancer Res. Treat. 91, 217–225 (2005)

    Article  Google Scholar 

  36. Pestalozzi, B.C., Zahrieh, D., Price, K.N., et al.: Identifying breast cancer patients at risk for central nervous system (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG). Ann. Oncol. 17, 935–944 (2006)

    Article  Google Scholar 

  37. Brown, L.M., Chen, B.E., Pfeiffer, R.M., et al.: Risk of second non-hematological malignancies among 376,825 breast cancer survivors. Breast Cancer Res. Treat. 106, 439–451 (2007)

    Article  Google Scholar 

  38. Howard, R.A., Gilbert, E.S., Chen, B.E., et al.: Leukemia following breast cancer: an international population-based study of 376,825 women. Breast Cancer Res. Treat. 105, 359–368 (2007)

    Article  Google Scholar 

  39. Marees, T., Moll, A.C., Imhof, S.M., et al.: Risk of second malignancies in survivors of retinoblastoma: more than 40 years of follow-up. J. Natl. Cancer Inst. 100(24), 1771–1779 (2008)

    Article  Google Scholar 

  40. Ryberg, M., Nielsen, D., Cortese, G., et al.: New insight into epirubicin cardiac toxicity: competing risks analysis of 1097 breast cancer patients. J. Natl. Cancer Inst. 100(15), 1058–1067 (2008)

    Article  Google Scholar 

  41. Schaapveld, M., Visser, O., Louwman, M.J., et al.: Risk of new primary nonbreast cancers after breast cancer treatment: a Dutch population-based study. J. Clin. Oncol. 26(8), 1239–1246 (2008)

    Article  Google Scholar 

  42. Kennecke, H., Yerushalmi, R., Woods, R., et al.: Metastatic behavior of breast cancer subtypes. J. Clin. Oncol. 28(20), 3271–3277 (2010)

    Article  Google Scholar 

  43. Scrucca, L., Santucci, A., Aversa, F.: Regression modeling of competing risk using R: an in depth guide for clinicians. Bone Marrow Transplant. 45, 1388–1395 (2010)

    Article  Google Scholar 

  44. Gail, M.H.: Estimation and interpretation of models of absolute risk from epidemiologic data, including family-based studies. Lifetime Data Anal. 14, 18–36 (2008)

    Article  MathSciNet  MATH  Google Scholar 

  45. Gail, M.H.: Personalized estimates of breast cancer risk in clinical practice and public health. Stat. Med. 30(10), 1090–1104 (2011)

    Article  MathSciNet  Google Scholar 

  46. Koller, M.T., Raatz, H., Steyerberg, E.W., et al.: Competing risks in the clinical community: irrelevance or ignorance? Stat. Med. 31, 1089–1097 (2012)

    Article  MathSciNet  Google Scholar 

Download references

Acknowledgements

We acknowledge the Natural Sciences and Engineering Research Council of Canada and the Canadian Institutes of Health Research for their financial support.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sharareh Taghipour .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer Science+Business Media New York

About this paper

Cite this paper

Taghipour, S., Banjevic, D., Miller, A., Harvey, B. (2013). Competing Risks Models and Breast Cancer: A Brief Review. In: Lee, ML., Gail, M., Pfeiffer, R., Satten, G., Cai, T., Gandy, A. (eds) Risk Assessment and Evaluation of Predictions. Lecture Notes in Statistics, vol 215. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-8981-8_14

Download citation

Publish with us

Policies and ethics